Sustained Release Steroid from HA Gel reduces complications after endoscopic sinus surgery

Written By :  MD Bureau
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-03-23 13:08 GMT   |   Update On 2023-10-16 09:30 GMT

Functional endoscopic sinus surgery (FESS) is often used to improve the prognosis of chronic rhinosinusitis. A study published in the European Archives of Oto-Rhino-Laryngology on September 04, 2020, suggests that the combination of self-crosslinked hyaluronic acid (scHA)/budesonide is effective in the postoperative management of functional endoscopic sinus surgery.Postoperative...

Login or Register to read the full article

Functional endoscopic sinus surgery (FESS) is often used to improve the prognosis of chronic rhinosinusitis. A study published in the European Archives of Oto-Rhino-Laryngology on September 04, 2020, suggests that the combination of self-crosslinked hyaluronic acid (scHA)/budesonide is effective in the postoperative management of functional endoscopic sinus surgery.

Postoperative complications such as nasal adhesions often cause the failure of endoscopic sinus surgery, resulting in poorer outcomes and a higher likelihood of revision surgery, with adverse effects on patients' health-related quality of life scores. Thus, the postoperative management methods are needed to be further investigated.

Hyaluronic acid has its broad application in ENT surgery, gynaecological surgery, orthopedical surgery, general surgery and cosmetic surgery. The modulating effect of hyaluronic acid in wound healing and mucosal regeneration has been demonstrated in clinical trials following nasal surgery, in which safety, tolerability and efficacy of hyaluronic acid were reported. However, the uses of unmodified hyaluronic acid in combination with steroids remain unclear. Therefore, researchers of the Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, conducted a study to investigate the efficacy and potential of scHA gel as a topical drug sustained-release carrier for the steroid of budesonide.

It was a randomized, controlled trial of 30 chronic rhinosinusitis with nasal polyps patients who underwent functional endoscopic sinus surgery. The control group received the single application of self-crosslinked hyaluronic acid and, the intervention group received the combination of scHA/budesonide. Researchers followed up the patients in 2 weeks, 4weeks and 12 weeks after surgery to assess the postoperative recovery.

Upon analysis, researchers found that the combination of scHA/budesonide results in better endoscopic scoring and mucus evaluation than the single self-crosslinked hyaluronic acid application.

The authors concluded, "The results indicate that the combination of scHA/budesonide is a valuable treatment for the FESS postoperative management and implies the potential of scHA gel as a topical drug sustained-release scaffold."

For further information:

https://doi.org/10.1007/s00405-020-06320-0


Tags:    
Article Source :  European Archives of Oto-Rhino-Laryngology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News